Niagen Bioscience, Inc. (NAGE)
2.01
-0.06
(-2.66%)
USD |
NASDAQ |
Nov 16, 16:00
1.96
-0.05
(-2.49%)
After-Hours: 20:00
Niagen Bioscience SG&A Expense (TTM) : 68.81M for Sept. 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 68.81M |
| June 30, 2026 | 67.81M |
| March 31, 2026 | 66.18M |
| December 31, 2025 | 62.56M |
| September 30, 2025 | 54.44M |
| June 30, 2025 | 51.89M |
| March 31, 2025 | 49.05M |
| December 31, 2024 | 47.84M |
| September 30, 2024 | 50.02M |
| June 30, 2024 | 48.55M |
| March 31, 2024 | 49.22M |
| December 31, 2023 | 51.42M |
| September 30, 2023 | 51.66M |
| June 30, 2023 | 51.83M |
| March 31, 2023 | 53.71M |
| December 31, 2022 | 56.60M |
| September 30, 2022 | 59.56M |
| June 30, 2022 | 65.93M |
| March 31, 2022 | 66.11M |
| December 31, 2021 | 64.69M |
| September 30, 2021 | 64.07M |
| June 30, 2021 | 57.41M |
| March 31, 2021 | 53.89M |
| December 31, 2020 | 51.40M |
| September 30, 2020 | 52.07M |
| Date | Value |
|---|---|
| June 30, 2020 | 52.89M |
| March 31, 2020 | 53.30M |
| December 31, 2019 | 52.52M |
| September 30, 2019 | 48.94M |
| June 30, 2019 | 47.95M |
| March 31, 2019 | 46.08M |
| December 31, 2018 | 43.67M |
| September 30, 2018 | 43.23M |
| June 30, 2018 | 36.68M |
| March 31, 2018 | 29.47M |
| December 31, 2017 | 22.10M |
| September 30, 2017 | 18.07M |
| June 30, 2017 | 15.03M |
| March 31, 2017 | 14.87M |
| December 31, 2016 | 14.68M |
| September 30, 2016 | 9.502M |
| June 30, 2016 | 9.793M |
| March 31, 2016 | 9.443M |
| December 31, 2015 | 9.743M |
| September 30, 2015 | 10.29M |
| June 30, 2015 | 10.16M |
| March 31, 2015 | 10.54M |
| December 31, 2014 | 10.51M |
| September 30, 2014 | 9.466M |
| June 30, 2014 | 9.254M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Nature's Sunshine Products, Inc. | 325.26M |
| Cyanotech Corp. | 9.168M |
| Mannatech, Inc. | 77.04M |
| Natural Alternatives International, Inc. | 17.03M |
| USANA Health Sciences, Inc. | 660.86M |